There still needs to be more education around what real-world evidence is, explained Jason Harris, associate director of policy and programs at National Health Council.
There still needs to be more education around what real-world evidence is, explained Jason Harris, associate director of policy and programs at National Health Council.
Transcript
What recommendations did the National Health Council come out with in its white paper on real-world evidence?
Recently, it’s been a real-world evidence year, if you will. We hosted a roundtable to solicit the patient perspective. We had close to 50 people in the room, about 15 experts from your more industry perspective and then about 30 patient organizations to just figure out what their concerns were, what their thoughts were, did they know about it. What we really learned from that is that overall, the concept is something that we need more education on, but once it’s explained and understood, it’s certainly something that patient organizations want to be involved in and we want to make sure that the ship doesn’t leave without insuring that perspective.
As you work with patients on real-world evidence, are you finding areas where their perceptions were not lined up with reality?
I think it’s a really good point. Overall, when we talk about the concept of what real-world evidence is and a patient hears that, they think for the most part it makes sense that it would be done because we are thinking of this high-tech era where we can use everything. It’s that understanding of well in healthcare, we are a little bit behind in terms of how we do things and so they were surprised that it wasn’t being done and that we weren’t quite there yet once they understood the concept.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More